Paper · 14499350
A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis.
Chen L and 4 others. Bone, 2003. Cited by 137 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis. Papers, record 14499350. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14499350
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acrocephalosyndactylia | Major topic |
| Bone Development | Major topic |
| Proto-Oncogene Proteins c-bcl-2 | Major topic |
| Receptor Protein-Tyrosine Kinases | Major topic |
| Receptors, Fibroblast Growth Factor | Major topic |
| Amino Acid Substitution | |
| Animals | |
| Apoptosis | |
| Cell Differentiation | |
| Cell Division | |
| Cranial Sutures | |
| Heterozygote | |
| Mice | |
| Mice, Mutant Strains | |
| Osteoblasts | |
| Phenotype | |
| Proto-Oncogene Proteins | |
| Receptor, Fibroblast Growth Factor, Type 2 | |
| Serine | |
| Signal Transduction | |
| Tryptophan | |
| bcl-2-Associated X Protein |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Z01DK056001 | NIH | NIH RePORTER | |||
| ZIADK056001 | NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by82
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 137 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,633,326 | Advances in FGF/FGFR Signaling: Implications for Disease and Therapy. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42633326 | PubMed |
| 42,049,724 | The role of Pth1r in posterior cranium cartilage regulation and craniosynostosis. | Nat Commun | 2026 | https://conductscience.org/library/papers/42049724 | PubMed |
| 41,632,539 | Stem cell-associated osteogenic deficiency causes craniofacial deformities with progeroid accumulation of prelamin A. | JCI Insight | 2026 | https://conductscience.org/library/papers/41632539 | PubMed |
| 41,318,657 | RAD51B-EZH2 axis as a potential therapeutic target for TNBC through cell fate conversion. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/41318657 | PubMed |
| 41,151,533 | FGF receptor 2 signaling in granulosa cells is required for normal female fertility in mice. | Reproduction | 2025 | https://conductscience.org/library/papers/41151533 | PubMed |
| 40,261,605 | Insight into Apert Syndrome: Reporting on Six Patients and Increasing Awareness. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/40261605 | PubMed |
| 39,158,595 | New CRISPR/Cas9-based Fgfr2C361Y/+ mouse model of Crouzon syndrome exhibits skull and behavioral abnormalities. | J Mol Med (Berl) | 2024 | https://conductscience.org/library/papers/39158595 | PubMed |
| 39,096,036 | Cranial bone microarchitecture in a mouse model for syndromic craniosynostosis. | J Anat | 2024 | https://conductscience.org/library/papers/39096036 | PubMed |
| 38,814,743 | Mesenchymal Wnts are required for morphogenetic movements of calvarial osteoblasts during apical expansion. | Development | 2024 | https://conductscience.org/library/papers/38814743 | PubMed |
| 38,602,508 | Apical expansion of calvarial osteoblasts and suture patency is dependent on fibronectin cues. | Development | 2024 | https://conductscience.org/library/papers/38602508 | PubMed |
1 to 10 of 82
See all 82 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| FGFR2 | 2,263 | PubTator's text mining | https://conductscience.org/library/genes/2263 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14499350
GET https://conductscience.org/api/papers/v1/14499350/cited_by?page=2